LAZIROS 25mg/ml powder for suspension for injection STADA
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Find medicines for human use by name or active substance.
Browse by initial
201–220 of 1,082 medicines
Active substance: azacitidine
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: myelodysplastic syndromes; acute myeloid leukemia
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: sodium chromoglycate
S01GX01 Sensory organs | Decongestants and antiallergics | Other antiallergics
Indicated for: allergic rhinitis; urticaria
Active substance: chlormethine
L01AA05 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: cancer
Active substance: demeclocycline + triamcinolone
Indicated for: inflammatory dermatoses
Active substance: demeclocycline + triamcinolone
Indicated for: inflammatory dermatoses
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: levomethadone
N07BC05 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
Indicated for: severe pain; opioid dependence
Active substance: levomethadone
N07BC05 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence
Indicated for: severe pain; opioid dependence
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
Active substance: leflunomide
Indicated for: rheumatoid arthritis
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.